Assets of Evogene Ltd. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD
Summary
Evogene Ltd. quarterly Assets in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • Evogene Ltd. Assets for the quarter ending 31 Dec 2024 was $39,864,000, a 22% decline year-over-year.
Source SEC data
View on sec.gov
Assets, Quarterly (USD)
Assets, YoY Quarterly Change (%)

Evogene Ltd. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $39,864,000 -$11,237,000 -22% 31 Dec 2024 20-F 27 Mar 2025 2024 FY
Q2 2024 $40,968,000 -$12,372,000 -23% 30 Jun 2024 6-K 16 Sep 2024 2024 Q2
Q4 2023 $51,101,000 -$5,025,000 -9% 31 Dec 2023 20-F 27 Mar 2025 2024 FY
Q2 2023 $53,340,000 -$3,322,000 -5.9% 30 Jun 2023 6-K 13 Sep 2023 2023 Q2
Q4 2022 $56,126,000 -$20,178,000 -26% 31 Dec 2022 20-F 28 Mar 2024 2023 FY
Q2 2022 $56,662,000 -$30,875,000 -35% 30 Jun 2022 6-K 07 Sep 2022 2022 Q2
Q4 2021 $76,304,000 +$4,389,000 +6.1% 31 Dec 2021 20-F 30 Mar 2023 2022 FY
Q2 2021 $87,537,000 +$26,431,000 +43% 30 Jun 2021 6-K 31 Aug 2021 2021 Q2
Q4 2020 $71,915,000 +$551,000 +0.77% 31 Dec 2020 20-F 31 Mar 2022 2021 FY
Q2 2020 $61,106,000 30 Jun 2020 6-K 15 Sep 2020 2020 Q2
Q4 2019 $71,364,000 +$12,670,000 +22% 31 Dec 2019 20-F 02 Apr 2021 2020 FY
Q4 2018 $58,694,000 -$18,908,000 -24% 31 Dec 2018 20-F 27 Apr 2020 2019 FY
Q4 2017 $77,602,000 -$18,384,000 -19% 31 Dec 2017 20-F 29 Apr 2019 2018 FY
Q4 2016 $95,986,000 31 Dec 2016 20-F 30 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.